// App-Quantinova.ai

e20560 : Efficacy and safety of tamibarotene or placebo added to paclitaxel/carboplatin for advanced non-small cell lung cancer.

Researchers

Presenter

  • Daniel J. Levitt

Principal Investigators

  • Scott Wieland

  • David Haen

  • Shanta Chawla

Medical Centers

  • CytRx Corporation, Los Angeles, CA

  • CytRx Corporation, Los Angeles, CA

Locations

  • United States

Companies

  • CytRx Corp.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Peripheral neuropathy

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Tamibarotene

  • Carboplatin

  • Paclitaxel

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • NCT01337154

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved